{
    "accession": "ENCBS038ZQB",
    "age": "15",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "deletion",
            "method": "CRISPR",
            "modified_site_by_target_id": "IGF2BP1",
            "purpose": "repression"
        }
    ],
    "biosample_term_id": "EFO:0001187",
    "biosample_term_name": "HepG2",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "RNA-seq on HepG2 cells treated with a CRISPR gRNA against IGF2BP1. (IGF2BP1_BGHcLV03-4)",
    "documents": [
        {
            "attachment": "/documents/f08f3256-32f0-4a46-8965-6cf9ac38a400/@@download/attachment/Graveley-HepG2-growth-protocol.pdf",
            "document_type": "growth protocol",
            "references": [],
            "urls": []
        },
        {
            "attachment": "/documents/7225997d-c540-4468-af8f-5aee4a7b5a88/@@download/attachment/IGF2BP1_BGHcLV03-4.pdf",
            "document_type": "general protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000AAC",
    "health_status": "hepatocellular carcinoma",
    "lab": "Brenton Graveley, UConn",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "ATCC",
    "summary": "Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting IGF2BP1",
    "treatments": []
}